Glaxo to develop new antibiotics
PHILADELPHIA -- A unit of drugmaker GlaxoSmithKline has a central role in a $200 million public-private project announced Wednesday to develop new antibiotics against biological terrorism and treat drug-resistant infections found in health care ...
